Electroacupuncture for Hypertension Patients With Chronic Kidney Disease
NCT ID: NCT01766427
Last Updated: 2013-12-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
90 participants
OBSERVATIONAL
2012-10-31
2013-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
2. To observe if different-time treatment having an impact on Hypertension Patients With Chronic Kidney Disease.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Electroacupuncture vs Sham Electrocupuncture for Mixed Urinary Incontinence
NCT05505526
Electroacupuncture of Different Treatment Frequency in Chronic Urinary Retention Caused by Lower Motor Neuron Lesions
NCT06354244
Acupuncture for Catheter-Related-Bladder Discomfort After Transurethral Surgery
NCT06196437
Acupuncture for Stress-predominant Mixed Urinary Incontinence
NCT04299932
Effect of Electroacupuncture on P6 Acupoint on Hypertensive Patients.
NCT04514068
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
morning electroacupuncture with pills
No interventions assigned to this group
afternoon EA with pills
No interventions assigned to this group
no EA group with pills
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* heart failure
* severe valvular disease
* sustained arrhythmias
* secondary hypertension excluded from renovascular hypertension
* acute cardiovascular events
* infection
15 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
YueYiDeng
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
YueYiDeng
Director of Department of Nephrology of Longhua hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shanghai Longhua hopsital
Shanghai, Shanghai Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2012LCSY026
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.